Barbara Kamm

2.5k total citations · 2 hit papers
11 papers, 1.9k citations indexed

About

Barbara Kamm is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Internal Medicine. According to data from OpenAlex, Barbara Kamm has authored 11 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 3 papers in Internal Medicine. Recurrent topics in Barbara Kamm's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Barbara Kamm is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Barbara Kamm collaborates with scholars based in United States, Canada and Germany. Barbara Kamm's co-authors include Roy Bullingham, Andrew Nicholls, Basil A. Molony, Sharon M. Anderson, J. Donald Easton, William K. Hass, Harold P. Adams, William Pryse‐Phillips, James C. Grotta and John W. Norris and has published in prestigious journals such as New England Journal of Medicine, Circulation and Neurology.

In The Last Decade

Barbara Kamm

10 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients

1989 832 citations William K. Hass, J. Donald Easton et al. New England Journal of Medicine profile →
Clinical Pharmacokinetics of Mycophenolate Mofetil

1998 690 citations Roy Bullingham, Andrew Nicholls et al. Clinical Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Kamm United States	9	699	616	509	363	356	11	1.9k
Hans‐H. Neumayer Germany	29	665 1.0×	237 0.4×	245 0.5×	389 1.1×	447 1.3×	75	2.7k
Ashley Irish Australia	33	362 0.5×	320 0.5×	424 0.8×	613 1.7×	526 1.5×	115	2.6k
Ernesto Paoletti Italy	26	964 1.4×	237 0.4×	101 0.2×	311 0.9×	380 1.1×	79	2.0k
Avry Chagnac Israel	24	430 0.6×	204 0.3×	441 0.9×	829 2.3×	474 1.3×	93	3.2k
H.-H. Neumayer Germany	18	223 0.3×	315 0.5×	89 0.2×	286 0.8×	204 0.6×	43	1.3k
Hamim Zahir United States	17	423 0.6×	248 0.4×	78 0.2×	200 0.6×	113 0.3×	52	1.3k
Wooseong Huh South Korea	26	282 0.4×	265 0.4×	482 0.9×	524 1.4×	406 1.1×	178	2.5k
G. Buccianti Italy	19	383 0.5×	63 0.1×	201 0.4×	249 0.7×	239 0.7×	49	1.7k
Wayne Tymchak Canada	23	1.5k 2.2×	103 0.2×	280 0.6×	566 1.6×	786 2.2×	65	2.4k
Christiane M. Erley Germany	22	387 0.6×	42 0.1×	347 0.7×	512 1.4×	454 1.3×	72	2.1k

Countries citing papers authored by Barbara Kamm

Since Specialization

Citations

This map shows the geographic impact of Barbara Kamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Kamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Kamm more than expected).

Fields of papers citing papers by Barbara Kamm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Kamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Kamm. The network helps show where Barbara Kamm may publish in the future.

Co-authorship network of co-authors of Barbara Kamm

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Kamm. A scholar is included among the top collaborators of Barbara Kamm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Kamm. Barbara Kamm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Bullingham, Roy, Andrew Nicholls, & Barbara Kamm. (1998). Clinical Pharmacokinetics of Mycophenolate Mofetil. Clinical Pharmacokinetics. 34(6). 429–455. 690 indexed citations breakdown →

2.

Parker, Adwoa, Roy Bullingham, Barbara Kamm, & Michael Hale. (1996). Pharmacokinetics of Oral Mycophenolate Mofetil in Volunteer Subjects with Varying Degrees of Hepatic Oxidative Impairment. The Journal of Clinical Pharmacology. 36(4). 332–344. 57 indexed citations

3.

Kamm, Barbara & Andreas Schief. (1994). Extension of stationary stochastic processes. Probability Theory and Related Fields. 100(1). 77–84.

4.

Grotta, James C., et al.. (1992). Prevention of stroke with ticlopidine. Neurology. 42(1). 111–111. 95 indexed citations

5.

Hass, William K., J. Donald Easton, Harold P. Adams, et al.. (1989). A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients. New England Journal of Medicine. 321(8). 501–507. 832 indexed citations breakdown →

6.

Waters, David D., Donna Freedman, Jacques Lespérance, et al.. (1987). Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease. Controlled Clinical Trials. 8(3). 216–242. 27 indexed citations

7.

Kamm, Barbara, et al.. (1984). Ticlopidine aspirin stroke study. Controlled Clinical Trials. 5(3). 298–298. 2 indexed citations

8.

Kamm, Barbara, et al.. (1984). The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics.. PubMed. 15. 273–8. 11 indexed citations

9.

Day, Richard O., Daniel E. Furst, Sydney H. Dromgoole, et al.. (1982). Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 31(6). 733–740. 75 indexed citations

10.

Cohn, Keith, et al.. (1979). Use of treadmill score to quantify ischemic response and predict extent of coronary disease.. Circulation. 59(2). 286–296. 94 indexed citations

11.

Hilberman, Mark, Barbara Kamm, Michael E. Tarter, & John J. Osborn. (1975). An evaluation of computer-based patient monitoring at Pacific Medical Center. Computers and Biomedical Research. 8(5). 447–460. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact